Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials | Zendy

Jeffrey E. Korte | Zendy; Paul Wakim | Zendy; Carmen La Rosa | Zendy; Harold I. Perl | Zendy

Open Access

Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials

Author(s) -

Jeffrey E. Korte,

Paul Wakim,

Carmen La Rosa,

Harold I. Perl

Publication year - 2011

Publication title -

substance abuse and rehabilitation

Language(s) - English

Resource type - Journals

ISSN - 1179-8467

DOI - 10.2147/sar.s23796

Subject(s) - ethnic group , medicine , clinical trial , population , race (biology) , demography , addiction , randomized controlled trial , demographics , clinical psychology , gerontology , psychiatry , environmental health , sociology , anthropology , botany , biology

Historically, racial and ethnic minority populations have been underrepresented in clinical research, and the recruitment and retention of women and ethnic minorities in clinical trials has been a significant challenge for investigators. The National Drug Abuse Treatment Clinical Trials Network (CTN) conducts clinical trials in real-life settings and regularly monitors a number of variables critical to clinical trial implementation, including the retention and demographics of participants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research